Raveum Appoints Global Biopharma Executive Chintan Ghedia to Board of Directors, Reinforcing Commitment to Trust, Access, and Global Real Estate Investing

Austin (Texas) [USA], January 7: Raveum, a global platform expanding access to institutional-grade U.S. real estate, today announced the appointment of Chintan Ghedia to its Board of Directors. His addition marks a strategic step in Raveum’s next phase of growth as the company scales its compliance-first model for global investors seeking exposure to U.S. real estate assets.

“Chintan understands that in the future of finance, regulatory integrity is the ultimate accelerator,” said Kabir Israni, CEO at Raveum. “As we bridge the gap for retail and emerging-market investors, his experience allows us to turn complex compliance into a competitive advantage—delivering a transparent, tech-enabled experience that opens the world’s markets to everyone.”

As a board member, Ghedia will advise on go-to-market strategy, strategic partnerships, and ensuring that Raveum remains nimble and disciplined as it broadens its footprint.

“Growing up in India, I saw firsthand how limited access to financial opportunity can shape, and sometimes restrict, an individual’s path to growth and prosperity,” said Ghedia. “That’s why Raveum’s mission deeply resonates with me – it is democratizing access to global real estate while building trust and advancing financial literacy.”

Chintan Ghedia is a results-driven pharmaceutical executive with over 20 years of experience commercializing life-changing cancer medicines across the world. Ghedia is recognized for complex launches, managed multi-market P&Ls, and elevating high-performing senior-level teams to launch and scale innovative cancer medicines across highly regulated, complex global markets.

With this appointment, Raveum strengthens its leadership as it continues building a globally inclusive, trust led U.S. real estate investment platform designed for long term participation and resilience.

About Raveum

Raveum is a global investment platform dedicated to expanding access to U.S. real estate through fractional ownership. Built on principles of transparency and institutional governance, Raveum provides a structured pathway for international investors to participate in high-quality real estate assets, fostering global financial inclusivity.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More